semaglutide oral form Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients Oral Semaglutide for Weight Loss

These results indicated that a daily intake of 35 g/kg body weight of BDF could be an effective intervention for human constipation, although further clinical trials are needed

Improved Metabolic Health: Beyond weight loss, GLP-1 medications can improve markers of metabolic health, such as blood sugar control and lipid profiles

However, no conclusive evidence exists that semaglutide increases thyroid cancer risk in humans

The medical profession is slow to change, and even slower to adopt new practices and new medicines

Recalls & Warnings June 12, 2025 NOW Nutritional Yeast Powder Recalled On May 8, 2025, Now Foods recalled 18,658 units of NOW Nutritional Yeast Powder because regular yeast was inadvertently packaged as nutritional yeast

GIPR-Ab/GLP-1 peptideantibody conjugate requires brain GIPR and GLP-1R for additive weight loss in obese mice